BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9650711)

  • 1. p53 protein and Kaposi's sarcoma.
    Noel JC; Simonart T
    Am J Dermatopathol; 1998 Jun; 20(3):322. PubMed ID: 9650711
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression and mutation of the tumor suppressor gene p53 in AIDS-associated Kaposi's sarcoma.
    Li JJ; Huang YQ; Cockerell CJ; Zhang WG; Nicolaides A; Friedman-Kien AE
    Am J Dermatopathol; 1997 Aug; 19(4):373-8. PubMed ID: 9261472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma-associated herpesvirus (KSHV): a new viral pathogen associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
    Said J
    West J Med; 1997 Jul; 167(1):37-8. PubMed ID: 9265864
    [No Abstract]   [Full Text] [Related]  

  • 4. Bcl-2 and p53 immunoprofile in Kaposi's sarcoma.
    Pillay P; Chetty R; Reddy R
    Pathol Oncol Res; 1999; 5(1):17-20. PubMed ID: 10079372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An IL-8 gene promoter polymorphism is associated with the risk of the development of AIDS-related Kaposi's sarcoma: a case-control study.
    van der Kuyl AC; Polstra AM; Weverling GJ; Zorgdrager F; van den Burg R; Cornelissen M
    AIDS; 2004 May; 18(8):1206-8. PubMed ID: 15166538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of human papillomavirus and p53 gene mutations in Kaposi's sarcoma.
    Scinicariello F; Dolan MJ; Nedelcu I; Tyring SK; Hilliard JK
    Virology; 1994 Aug; 203(1):153-7. PubMed ID: 8030271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 protein overexpression is a common but late event in the pathogenesis of iatrogenic and AIDS-related Kaposi's sarcoma.
    Noel JC; De Thier F; Simonart T; Andre J; Hermans P; Van Vooren JP; Heenen M
    Arch Dermatol Res; 1997 Oct; 289(11):660-1. PubMed ID: 9444391
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibroblast growth factor gene expression in AIDS-Kaposi's sarcoma detected by in situ hybridization.
    Xerri L; Hassoun J; Planche J; Guigou V; Grob JJ; Parc P; Birnbaum D; deLapeyriere O
    Am J Pathol; 1991 Jan; 138(1):9-15. PubMed ID: 1987771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purified Tat induces inflammatory response genes in Kaposi's sarcoma cells.
    Kelly GD; Ensoli B; Gunthel CJ; Offermann MK
    AIDS; 1998 Oct; 12(14):1753-61. PubMed ID: 9792375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of p53 and Ki-67 proteins in classic and iatrogenic Kaposi's sarcoma.
    Hodak E; Hammel I; Feinmesser M; Zelinger A; Maron L; Sulkes J; David M
    Am J Dermatopathol; 1999 Apr; 21(2):138-45. PubMed ID: 10218673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patients.
    Gayà A; Esteve A; Casabona J; McCarthy JJ; Martorell J; Schulz TF; Whitby D;
    AIDS; 2004 Jan; 18(2):199-204. PubMed ID: 15075536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin.
    Husain SR; Gill P; Kreitman RJ; Pastan I; Puri RK
    Mol Med; 1997 May; 3(5):327-38. PubMed ID: 9205948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular tumors produced by NIH/3T3 cells transfected with human AIDS Kaposi's sarcoma DNA.
    Lo SC; Liotta LA
    Am J Pathol; 1985 Jan; 118(1):7-13. PubMed ID: 4038436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kaposi-sarcoma].
    Sinkovics J; Szakács J; Horváth J; Györkey F; Györkey P; Gergely AS
    Orv Hetil; 2006 Apr; 147(13):617-21; author reply 621. PubMed ID: 16623444
    [No Abstract]   [Full Text] [Related]  

  • 15. Kaposi's sarcoma and central nervous system disease: a real association or an artifact of the control group? Terry Beirn Community Programs for Clinical Research on AIDS.
    Eberly LE; Ohman PA; Neaton JD; Price RW; Abrams DI
    AIDS; 2000 May; 14(8):995-1000. PubMed ID: 10853981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma in HIV infection: impact on opportunistic infections and survival.
    Brodt HR; Kamps BS; Helm EB; Schöfer H; Mitrou P
    AIDS; 1998 Aug; 12(12):1475-81. PubMed ID: 9727568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of European patients with Kaposi's sarcoma as AIDS-defining condition during the first decade of AIDS. AIDS in Europe Study Group.
    Hermans P; Lundgren J; Sommereijns B; Katlama C; Chiesi A; Goebel FD; Gonzales-Lahoz J; Proenza R; Barton SE; Pedersen C; Clumeck N
    AIDS; 1997 Mar; 11(4):525-31. PubMed ID: 9084801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus.
    Engels EA; Pittaluga S; Whitby D; Rabkin C; Aoki Y; Jaffe ES; Goedert JJ
    Mod Pathol; 2003 May; 16(5):424-9. PubMed ID: 12748248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma.
    Masood R; Cai J; Zheng T; Smith DL; Naidu Y; Gill PS
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):979-84. PubMed ID: 9023368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 6 gene expression in AIDS-associated Kaposi's sarcoma.
    Huang YQ; Li JJ; Nicolaides A; Zhang WG; Freidman-Kien AE
    Lancet; 1992 May; 339(8801):1110-1. PubMed ID: 1349122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.